GARY FLOYD MILECHMAN
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease SAN FRANCISCO, CA NPI 1851483531
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease CA Lexicon Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$9,953.73
- Category: General Payments
- Program years: PY2018–2024
- Record count: 212
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $686.36 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $686.36 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lexicon Pharmaceuticals, Inc. | $210.38 | 2 |
| IMPULSE DYNAMICS (USA) INC. | $170.73 | 1 |
| Amgen Inc. | $150.39 | 1 |
| Kiniksa Pharmaceuticals International, plc | $121.26 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $33.60 | 2 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1081733221 | Lexicon Pharmaceuticals, Inc. | $85.40 | 04/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1081733223 | Lexicon Pharmaceuticals, Inc. | $124.98 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1092728078 | Boston Scientific Corporation | $16.80 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1092728080 | Boston Scientific Corporation | $16.80 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100423207 | Impulse Dynamics (USA) Inc. | $170.73 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111652119 | Amgen Inc. | $150.39 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154862278 | Kiniksa Pharmaceuticals International, plc | $121.26 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.